B0B8X5 AF NFT

Alanine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidxnqxf4wqzzmqqbql3szaqa2rwej4vefuzgogfg7ofasdvjm45cy/metadata.json
IPFS of structure file: 
bafybeidbjj4sedee2trk4tffypmumqgtcukjdpgttnqmckxsvvb7zm7pji/AF-B0B8X5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x973C5CD9497387314A320A94e253854ADfB470BF
First NFT owner address (bech32): 
genesis1ju79ek2fwwrnzj3jp22wy5u9ft0mgu9lu850lz
Current NFT ID #442992 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
442992
Accession (UniProt):
B0B8X5
Name::
Alanine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
CHLAMYDIA TRACHOMATIS SEROVAR L2 (STRAIN 434/BU / ATCC VR-902B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0B8X5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0B8X5|SYA_CHLT2 Alanine--tRNA ligase OS=Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) OX=471472 GN=alaS PE=3 SV=1 MLSNTLRSNFLKFYANRNHTPVASSPVFPHNDPSILFTNAGMNQFKNIFLGKEQTSYTRATTSQKCIRAGGKHNDLENVGHTSRHLTFFEMLGNFSFGDYFKQDAISFAWEVSLSVFNFDPDFIYATVHEKDDEAFALWEKYLPTDRIFRLTDKDNFWSMADTGPCGFCSELLFDRGEKFGKAASPLEDVDGERFLEYWNLVFMEFNRTSDGTLLALQKKCVDTGAGLERLVSLLAETKTVFEADVLRHLISKIENLSGTTYSPTEAKGAAFRVIADHIRSLSFAIADGLLPGNTERGYVLRKILRRAVNYGKRLGFNRPFLADVVPSLVDVMGEAYPELSASVTQIQEVLTTEEEHFFKTLQRGGNLLQQVLKSSASSAKISGEDAFKLKDTYGLPIDEIALLAKDYNYAIDMDTFEKLEVEAKERSRKNTKKTKNDSDSVFQDLDPTNTSEFIGYDTLSCDTFIEGIIKYNEIASSLEEGDEGAIILRTTPFYAEKGGQIGDSGEIFCESGTFLVSHTIAPKAGLIVHLGKLSQGSLTTTMAVTAQVNQNLRKKTANNHTGCHLLHKALEMTLGEHIRQAGSYVDSQKIRLDFTHNKALSPEDLLAIETLVNEKIRENDPVTIREVLYSDVMSSSEIKQFCGDKYGDIVRVVLAGFSHELCGGTHAQATGDIGYFRITKEHAVATGIRRIEATTGEDAENIARGQDVDLNEIATVIQSPKDQILVKIRSVMEEKKDLAKQVADLENQLVQQQVKTLLTSCEKICDTSYLVYYLTEEEGQRIQHYANAIHKEIPTNFISLWITEKNGRYIVLSRVSDDLTKRGVQAHTLLAELLAPYGGRCGGKAISAQGSSAELPQIEFLNKTLRQWISTQLA